| 000 | 01803 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250513200135.0 | ||
| 264 | 0 | _c20000120 | |
| 008 | 200001s 0 0 eng d | ||
| 022 | _a0278-0240 | ||
| 024 | 7 |
_a10.1155/1999/241046 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClaes, K | |
| 245 | 0 | 0 |
_aMutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5 + 3A > G. _h[electronic resource] |
| 260 |
_bDisease markers _cOct 1999 |
||
| 300 |
_a69-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge of Onset |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 | _aBRCA2 Protein |
| 650 | 0 | 4 |
_aBreast Neoplasms _xepidemiology |
| 650 | 0 | 4 |
_aDNA Mutational Analysis _xmethods |
| 650 | 0 | 4 |
_aExons _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFounder Effect |
| 650 | 0 | 4 | _aGenes, BRCA1 |
| 650 | 0 | 4 | _aGenetic Counseling |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGenetic Testing |
| 650 | 0 | 4 |
_aHaplotypes _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrosatellite Repeats |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xgenetics |
| 650 | 0 | 4 |
_aNeoplastic Syndromes, Hereditary _xepidemiology |
| 650 | 0 | 4 | _aOncogenes |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aRNA Splicing |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 |
_aTranscription Factors _xgenetics |
| 700 | 1 | _aMachackova, E | |
| 700 | 1 | _aDe Vos, M | |
| 700 | 1 | _aPoppe, B | |
| 700 | 1 | _aDe Paepe, A | |
| 700 | 1 | _aMessiaen, L | |
| 773 | 0 |
_tDisease markers _gvol. 15 _gno. 1-3 _gp. 69-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1155/1999/241046 _zAvailable from publisher's website |
| 999 |
_c10551329 _d10551329 |
||